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MitochondriaVoltage-dependant Anion Channels, also known as mitochondrial porins, are pore-forming proteins located
in the mitochondrial outer membrane (MOM) that, in addition to forming complexes with other proteins
that localize to the MOM, also function as the main conduit for transporting metabolites between the cyto-
plasm and mitochondria. VDACs are encoded by a multi-member gene family, and the number of isoforms
and speciﬁc functions of VDACs varies between species. Translating the well-described in vitro characteristics
of the VDAC isoforms into in vivo functions has been a challenge, with the generation of animal models of
VDAC deﬁciency providing much of the available information about isoform-speciﬁc roles in biology. Here,
we review the approaches used to create these insect and mammalian animal models, and the conclusions
reached by studying the consequences of loss of function mutations on the genetic, physiologic, and bio-
chemical properties of the resulting models. This article is part of a Special Issue entitled: VDAC structure,
function, and regulation of mitochondrial metabolism.
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Voltage-dependent Anion Channels (VDACs) are the most abun-
dant proteins in the mitochondrial outer membrane (MOM) [1], a
key region of the organelle that plays a central role in various cellular
processes, including metabolite ﬂux, metabolic compartmentation,
and apoptosis. Not surprisingly, VDACs have been implicated in all
of these processes via differing mechanisms: facilitating metabolite
ﬂux by enabling transport of ATP, ADP, phosphocreatine and other
small ions across the MOM [2,3], anchoring hexokinases to the
MOM during glycolysis [4] and aiding release of cytochrome c from
the intermembrane space, either directly regulation pore opening
and closure [5,6] and/or indirectly by interacting with Bcl-2 family
members [7] (reviewed in Ref. [8]). The diversity in function is
matched by the evolution of different isoforms of the protein, each
with distinct roles in mitochondrial biology, and comparing and con-
trasting the functional characteristics of these variants in different
model systems will be the focus of this review. Since the ﬁrst studies
to isolate the relevant genes and characterize the functional roles of
porins were conducted in yeast, and later studies were conducted in
ﬂies and mammals, we will analyze the models for porin deﬁciency
in that order.
2. Yeast VDAC isoforms
VDACs have been characterized in a variety of eukaryotes, with
the number of isoform variants ranging from one to perhaps ﬁve,
depending on the species [1,9,10,11]. The yeast (Saccharomyces
cerevisiae) variants of VDAC; YVDAC1 and YVDAC2, are encoded by
the single copy genes POR1 and POR2, respectively, with the proteins
having a 49% amino acid identity. POR1 is considered the major iso-
form in yeast, with the ability to form channels in phospholipid mem-
branes [12]. The POR1 deletion strain (Δpor1) exhibited a delayed
growth adaptation in non-fermentable glycerol at 30 °C, and a com-
plete lack of growth at 37 °C [13]. In addition to the growth pheno-
types, the deletion strain also demonstrated signiﬁcantly reduced
levels of mitochondrial cytochromes; cytochrome c,c1,b and aa3,
along with COXIV, while containing normal levels of other mitochon-
drial proteins. The ability of the deletion strain Δpor1 M22-2 to grow
at lower temperature led to a multi-copy suppressor screen for a
functional substitute for YVDAC1, resulting in the discovery of
YVDAC2. The YVDAC2 isoform, however, was neither able to form
channels in reconstituted in vitro systems nor rescue the growth
phenotype, and its true function remains to be determined [12].
Yeast has been used extensively as a model system for various mito-
chondrial dependent processes including, amongst others, the release
of cytochrome c during apoptosis. Conﬂicting reports have argued
for [14,15,16,17] and against the necessity of YVDAC1 [18,19] for
cytochrome c release during apoptosis. Other processes where a
role for YVDAC1 has been proposed include as a channel for metabo-
lites such as NADH, and as a conduit for reactive oxygen species (ROS)
signaling via redox regulation and consequent regulation of mRNA
and protein levels in the cell. [20,21,22,23]. YDAC1 has been hypoth-
esized to control cellular redox states by the transport of ROS species
such as the superoxide anion (O2−) across the MOM, and this in term
is known to affect cellular mRNA and protein levels (reviewed in Ref.
[21]). Over-expression or POR1 complementation in yeast of yeast,
fruit ﬂy and mammalian VDACs has also been an important tool in
isolating abundant amounts of puriﬁed VDAC protein and examining
the consequences of engineered point mutations with regard to struc-
ture and function [10,24,25].
3. Fly VDAC/porin isoforms
As described earlier in this review, while VDAC has been classical-
ly viewed as the major determinant of MOM since the 1970s, studiesover the past 15 years have clearly demonstrated that VDAC also
interacts with both cytosolic and MOM proteins (reviewed in
Ref. [26]). For example, VDAC integrates mitochondrial and cytoplas-
mic energy metabolism through its binding of hexokinases, effective-
ly linking glycolysis and mitochondrial oxidative phosphorylation, in
addition to being the possible mitochondrial docking site for glycerol
kinase and creatine kinase [26]. The fruit ﬂy provides a powerful
genetic model system to identify and further characterize VDAC func-
tions. Drosophila melanogaster contains a cluster of four genes (porin,
CG17137 [Porin2], CG17139, and CG17140) that encode proteins that
are homologous to known VDACs [25]. porin exhibits the greatest
homology to mammalian VDACs and is ubiquitously expressed in
the fruit ﬂy, while the other three ﬂy VDACs have a more spatially
restricted expression pattern, predominantly in the male reproduc-
tive tract [25]. A series of hypomorphic alleles has been generated
and characterized using imprecise excision of a P element inserted
in the 5′ untranslated region [27] of porin [28]. Flies lacking porin
exhibit a variety of mutant phenotypes including partial developmen-
tal lethality, abnormal mitochondrial respiration, partial complex I
deﬁciency, fertility defects, skeletal muscle abnormalities and neuro-
logical dysfunction. The fertility defects include reduced fertility and
fecundity in females and infertility in males associated with sperm
immotility. Themuscle phenotype consists of abnormalmitochondrial
morphology with unusual inclusions by electron microscopy as well
as a functional deﬁcit manifested as a defect in a climbing assay. The
neurological dysfunction in porin-deﬁcient ﬂies is manifested by
an increased sensitivity to mechanical stress (“bang sensitivity”),
progressive retinal dysfunction demonstrated by an abnormal electro-
retinogram (ERG), and an aberrant electrophysiological response at
the larval neuromuscular junction (NMJ). The neurological dysfunc-
tion at the larval NMJ is also characterized by an abnormal distribution
of mitochondria within the motor neuron. Using a mitochondria-
targeted GFP transgene expressed in the motor neuron, the quantity
of mitochondria in the presynaptic termini and axons is signiﬁcantly
reduced, with concomitant accumulation of mitochondria in motor
neuronal cell bodies [28]. Park et al. also recently reported phenotypic
characterization of ﬂy mutants deﬁcient for porin which conﬁrms the
neurological andmale infertility phenotypes, aswell as demonstrating
that the observed abnormal mitochondrial morphology can be res-
cuedwith overexpression of Drp1, a regulator of mitochondrial ﬁssion
[29]. This observation suggests that porin may play an important role
in the regulation of mitochondrial dynamics [29]. The phenotypes of
defective energymetabolismwith perturbedmitochondrial dynamics,
male infertility with sperm immotility, and neurological dysfunction
in porin-deﬁcient fruit ﬂies are reminiscent of abnormal phenotypes
seen in mitochondrial diseases and suggest that porin deﬁciency in
the ﬂy is a valid model of mitochondrial dysfunction that is relevant
both for rare primary mitochondrial diseases and for common adult
neurological andmetabolic diseases for whichmitochondrial dysfunc-
tion has been implicated to play a pathogenic role.
4. Mammalian VDAC isoforms
4.1. Gene organization
A prerequisite to understanding the functional characterization
of mammalian VDACs is a description of the organization of the
three VDAC isoforms in mammals. In mammals, three VDAC isoforms;
VDAC1, VDAC2 and VDAC3, have been characterized, with VDAC1 and
VDAC3 shown to have 9 exons and VDAC2 having 10, the additional
exon encoding part of the 5′-UTR region [30,31]. There is roughly
70% nucleotide sequence identity amongst the three VDAC isoforms
and around 90% nucleotide identity between the human and mouse
variants (henceforth referred to as mVDACs for mice and hVDACs
for humans) [30]. All three isoforms in humans and mice have the
start codon located in the second exon, span varying lengths of
Fig. 1. Gene structures of human VDAC isoforms with their reported alternate spliced variants (not drawn to scale). Predicted putative exons are shown in dashed boxes. Alternate
polyadenlyation sites are marked with arrows for hVDAC2. Translated regions are ﬁlled boxes, untranslated regions are not ﬁlled. The predicted start codons of the isoforms are
shown, along with the ATG mini-exon for hVDAC3 (in italics). The vertical arrows represent the multiple polyadenylation sites found in the VDAC2 gene. See text for details.
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relationship between the two species [32]. There is also a conserva-
tion of coding exon–intron boundaries and a splice acceptor bound-
ary for all three mVDACs, indicative of a gene family that arose by
gene duplications and divergence. The most signiﬁcant sequence dif-
ference amongst the isoforms is the presence of an 11–12 amino acid
amino terminal extension that is limited to VDAC2, the functional
signiﬁcance of which remains undetermined.
4.2. Alternative splicing
Based on searches of expressed sequence tag (EST) and sequence
databases, it was uncovered that there are alternate spliced exon
variants for hVDAC1 and hVDAC2, although the functional roles of
these variants, if any, remain unexplained [26,33]. The hVDAC1 splice
variant has a 157 bp alternative exon (referred to in Ref. ([26] as
exon1bis) located downstream of exon1 in the 5′-UTR region. It ap-
pears to be a true exon with a 3′ consensus splicing sequence and en-
codes for a fusion transcript of exon1bis with exons 2–9. The authors
also reported another possible longer alternate exon (referred to as
exon 0) in the 5′-UTR region, with several ESTs and a whole transcript
listed in EST collections and GenBank, respectively. It follows from
the locations of the exons (in the 5′-UTR region) that neither variant
alters the resulting protein sequence; hence the signiﬁcance of these
transcripts is not clear. The hVDAC2 gene, in contrast, was reported to
have an alternate exon (referred to as exon2 bis) between exons 2
and 3 corresponding to a 26 amino acid extension at the N-terminal
region instead of the 11–12 amino acid sequence. This variant corre-
sponded to a VDAC2 protein termed Humpor that already been
reported by Ha et al. in an earlier publication [34]. The functional con-
sequences of this extension, likewise, are unclear [34]. The human
VDAC3 gene has an additional alternatively spliced internal 3-base
(ATG) mini-exon between the exon 3 and exon 4 splice junctions,
1.9 Kb downstream of exon 3 and surrounded by splice enhancer
elements. It is predicted to result in the insertion of a methionine at
amino acid position 39 [26]. An identical variant has also been
described in the rat and mouse VDAC3 genes [26,35,36] (A map ofthe gene structure of the three isoforms and the splice variants is
shown in Fig. 1). Since the VDAC3 mini-exon is a start codon and
appears to have a stronger Kozak consensus sequence than the anno-
tated 5′ start site, it was proposed that this could initiate the transla-
tion of a truncated protein downstream of the native site [36].
A complementation analysis of the yeast porin-deletion mutant
with the full-length and truncated mVDAC3 cDNA provided an inter-
esting outcome, where the full-length construct failed to complement
the growth deﬁciency in the mutant (a previously observed result),
while the truncated cDNA rescued the mutant phenotype. While
trivial explanations such as translation efﬁciency could explain this
difference, it was proposed that the deletion of the ﬁrst 39 residues
could result in a constitutively open channel. Amino acid substitu-
tions of the inserted methionine residue with neutral residues that
do not disrupt protein structure failed to complement the growth
phenotype. On the other hand, substitutions with charged amino
acids produced a full rescue, potentially highlighting the importance
of the N-terminal region and its structural integrity in VDAC3 func-
tion. Despite the above experiments, investigation by Western blot-
ting of this truncated protein using epitope-tagged constructs and
highly speciﬁc antibodies failed to demonstrate expression of this
truncated isoform in mammalian cells, bringing into question its bio-
logical relevance [36,37]. The alternatively spliced VDAC3 mini-exon
is expressed in brain, heart and skeletal muscle to varying levels,
with the heart showing a higher expression of this variant compared
to the unspliced isoform, andmost other tissues having minimal or no
expression of the alternate variant. While the expression of this alter-
nate variant in tissues with high metabolic potential raises interesting
possibilities about its functional implications in vivo, there remain
many unanswered questions about the potential post-translational
functions of this splice variant.
4.3. Alternative polyadenylation
Another possible mechanism of post-transcriptional regulation
observed for the VDAC genes is the alternate polyadenylation of the
transcripts, resulting in varying lengths of the 3′-UTR region. While
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polyadenylation site, the mVDAC2 gene encodes multiple transcripts
of varying lengths, most likely because of its alternate polyadenyla-
tion sites [10]. Based on 3′-RACE experiments, the 3′-UTR region
was shown to have one aberrant and two canonical polyadenylation
sites, with, based on Northern blot analysis, the shortest product
being the most abundantly expressed. The differing lengths of the
3′-UTR regions of the mVDAC2 transcript could have functional
consequences for mRNA turnover, translation efﬁciency, the sub-
cellular location of transcripts [38,39,40], and, perhaps more interest-
ingly, miRNA binding that could regulate tissue-speciﬁc expression of
transcripts- areas which are open for further investigation [41,42,43].
A similar set of transcripts of varying sizes based on the polyadenyla-
tion sites has also been reported for hVDAC2 [44].
4.4. Tissue-speciﬁc expression
It has been observed that there is differential expression of both
VDAC1 and VDAC2 across different tissues in mice, with the highest
levels for both isoforms observed in heart, liver, skeletal muscle
and brain as measured by Northern blotting. Interestingly, while
mVDAC1 is expressed in very low levels in the testes, there is a high
level of expression of mVDAC2 in the same tissue [30]. The prototypic
mVDAC3 isoform is expressed in testes, liver, ovary, adrenal, lung,
spleen, and kidney, as measured by RT-PCR [37].
4.5. Functional conservation of VDACS
As an additional demonstration of functional conservation, and to
characterize the translational and functional nature of the proteins
encoded by mVDAC isoforms, rescue experiments were carried out
by transfecting the mouse cDNA orthologues ﬂanked by the yeast
VDAC promoter, 5′-UTR, and 3′-UTR, into the yeast porin mutant
Δpor1. It was found that while mVDAC1 and mVDAC2 cDNAs
completely rescued the temperature-sensitive growth deﬁciency of
the yeast mutant, mVDAC3 cDNA facilitated only a partial rescue,
with comparatively far fewer colonies growing at the restrictive
temperature of 37 °C [10]. A similar experiment also showed that
while each isoform increased the MOM permeability of the deletion
strain to NADH, the order of decreasing permeability was mVDAC1>
mVDAC2>mVDAC3. The electrophysiological properties of each
isoform, characterized by planar lipid reconstitution experiments,
also showed signiﬁcant variation, with mVDAC1 acting as the canoni-
cal VDAC, showing normal membrane insertion, conductivity and
selectivity, while mVDAC2 behaved as two populations of molecules,
with one having lower conductance and selectivity compared to pro-
typical porin. mVDAC3 showed normal insertion into planar lipid
membranes but did not exhibit any clear voltage-dependency inTable 1
Comparison of the genomic organization of the mammalian VDAC isoforms.
VDAC1
▪ Number of exons 9
▪ Alternate spliced isoform 2
▪ Alternate protein sequence No
▪ Percentage cDNA sequence identity between
mouse and human isoformsa
90%
▪ Percentage cDNA identity between mouse isoforms With mVDAC2-71%
With mVDAC3-68%
▪ Chromosomal location mVDAC1-Chr11
hVDAC1-Chr5
▪ Tissues showing highest expression in mice Heart, liver, skeletal
muscle and brain
a Comparison with the canonical splice variant.conductance and selectivity. All three isoforms were able to confer
polyethylene glycol permeability to liposomes, with similar molecular
weight cut-offs of between 3400 and 6800 Da [45]. The functional
reconstitution of VDACs in a yeast deletion background was also
performed with hVDAC1 and hVDAC2 cDNAs, with similar results
[33]. hVDAC1 was ascribed to be the canonical VDAC in terms of
voltage-dependence and conductance, while hVDAC2 appeared to be
present in a sub-conductance state, losing its voltage-dependence
with time. Both constructs managed to rescue the temperature-
sensitive growth phenotype of the POR1 deletion strain, and hVDAC1
was able to bind to hexokinase when expressed in yeast mitochondria,
providing additional support for the functional conservation of mito-
chondrial porins. A summary of the differences in gene organization
between the three isoforms is tabulated in Table 1.5. VDAC deﬁciency: Embryonic stem cells
The ﬁrst report describing a deletion model for mammalian VDACs
used homologous recombination to knockout each of the three VDAC
isoforms in mouse embryonic stem (ES) cells [46]. This approach
was used to delete exons 2–5 for VDAC1, the promoter and exons 1
and 2 (including the start codon) for VDAC2 and exons 6–9 for
VDAC3, and homologous recombination strategies were used to dis-
rupt both alleles present in the ES cells, generating isoform-speciﬁc
and completely deﬁcient cells. The deletions provided evidence for
another distinction between the three isoforms, in that while ES cells
harboring each of the three deletions showed a signiﬁcant reduction
in oxygen consumption, VDAC3−/− cells did not show a statistically
signiﬁcant difference from wildtype ES cells in uncoupled respiration,
reminiscent of the previously mentioned yeast rescue results (in
the section on Yeast VDAC isoforms). In addition, while cells lacking
VDAC1 showed a signiﬁcant increase in citrate synthase activity,
reﬂecting a possible compensatory proliferative effect on mitochon-
dria, a similar phenotype was not observed for VDAC2−/− and
VDAC3−/− cells. When the COX activity of the three deletions cell
types was measured, after normalization to mitochondrial content
based on the citrate synthase activity, VDAC1−/− and VDAC2−/−
cells showed a signiﬁcant reduction of COX activity, potentially
explained by the possible impairment of outer membrane transport
concomitantly coupled to reduced inner membrane respiration. Also
observed was a reduction in hexokinase activity in all three cell
types, reminiscent of results later observed in mutant mouse tissue.
A potentially compensatory increase in VDAC1 protein levels in the
VDAC2−/− and VDAC3−/− cells was also observed, providing a possi-
ble explanation of the lack of mitochondrial proliferation in these
cell types. While there are clear limitations in approaching isoform
function in a single cell type such as ES cells, it is apparent from the
divergent range of bioenergetic phenotypes between the threeVDAC2 VDAC3 Ref.
10 9 [30,31]
1 1 [26,34,37]
Yes Yes [26,34,37]
90% 68% with hVDAC1
73% with hVDAC2
[30,31]
With mVDAC1-71%
With mVDAC3-73%
With mVDAC1-68%
With mVDAC2-73%
NCBI database
mVDAC2-Chr14
hVDAC2-Chr10
mVDAC3-Chr8 [30,32]
Heart, liver, skeletal
muscle and brain
Testes, liver, ovary, adrenal,
lung, spleen, and kidney
[30],[36]
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each isoform in the cell, and this is reﬂected in the deletion mouse
models elaborated upon in the following sections.
6. VDAC deﬁciency in mice
6.1. Survival and growth
In this section, observations made in mice lacking the VDAC1 and
VDAC3 isoforms will be reviewed, and brief mention will be made
about as yet unpublished ﬁndings in VDAC1 and VDAC2 deﬁcient
mice. VDAC1+/− and VDAC3+/− ES cells were used to obtain mouse
chimeras, and subsequent heterozygous mice tested for Mendelian
transmission of the deletion mutations [47]. While the mutant and
wildtype alleles of the VDAC3 locus were transmitted in the expected
Mendelian ratios, VDAC1−/− mice were born in less than expected
numbers, indicative of partial embryonic lethality. This lethality was
shown to occur at 10.5–11.5 days of embryogenesis and was inﬂu-
enced by the strain background. While the VDAC1 mutation bred
onto an inbred C57Bl6 background showed almost complete lethality,
outcrossing to the mixed CD-1 background increased the survival
rate to around 70% of the expected frequency [48]. The surviving
VDAC1−/− mice were fertile and showed mild growth retardation,
while the VDAC3−/− male mice were found to be infertile, and the
VDAC1−/−/VDAC3−/− double knockout offspring similarly showed
reduced Mendelian ratios, infertility, and more severe growth
retardation.
6.2. Regulating synaptic plasticity through the MPTP
VDACs have long been proposed to be a part of the Mitochondrial
Permeability Transition Pore complex (MPTP) [49,50,51], although
the evidence for this has been debated (reviewed in Ref. [52]).
Amongst a wide range of purported functions, the MPTP has been
implicated in learning and synaptic plasticity based upon its role in
mitochondrial calcium buffering, ATP production, and metabolite
ﬂux at the synapse [53], [54]. With both VDAC1 and VDAC3 protein
present in cells of the hippocampus, the VDAC1−/−, VDAC3−/− and
VDAC1−/−/VDAC3−/−mice were investigated for learning and stable
memory phenotypes, since both processes require synaptic plasticity;
the experience-related changes in synaptic strength [47]. Although
none of the three mutant strains exhibited hippocampal structural
alterations, both VDAC3−/− and VDAC1−/−/VDAC3−/− mice demon-
strated a signiﬁcant reduction in contextual fear conditioning. This
test involves pairing an aversive stimulus such as a mild foot shock
with an auditory-conditioned stimulus such as white noise that is
provided in a particular visual context, with the expected result
being fear and freezing in response to the visual training context.
This was not observed for the VDAC1−/− mice, speciﬁcally implicat-
ing VDAC3 in hippocampus-dependant contextual fear conditioning.
However, all three genotypes showed a deﬁcit in cued fear condition-
ing, where the same conditioned fear experiment is performed with
the re-presentation of the auditory cue in a different visual context.
A possible explanation for this phenotypic difference is varying con-
tributions of VDACs to different regions of the amygdaloid nuclei,
which are known to play a role in contextual and cued fear condition-
ing. The three strains were then subject to a spatial learning paradigm
using the Morris water maze, where the mice are tested on their abil-
ity to remember and ﬁnd the location of a hidden platform when
placed in opaque water. All three mutants showed a signiﬁcant defect
in spatial learning, another hippocampus-dependant process that
reﬂects a higher order cognitive function than that of fear condition-
ing. To rule out sensory or motor deﬁcits as confounding factors in
these tests, hot-plate, open-ﬁeld activity, and locomotor tests were
conducted and the mutant mice performed identically to wildtype
controls, indicating that the defects reﬂected a speciﬁc abnormalityin synaptic plasticity and not simply sensory deﬁcits or a global
impairment in brain function [48].
To investigate which parameters of synaptic plasticity could ac-
count for the observed associative and spatial learning and memory
phenotypes, hippocampal slices were subject to electrophysiologic
testing paradigms and analyzed for short-term and long-term synap-
tic plasticity. Paired pulse facilitation (PPF) is a measure of presynap-
tic plasticity where two temporally close-spaced depolarizations
augment synaptic transmission, and is thought to reﬂect the effect
of residual calcium caused by the ﬁrst depolarization. In contrast,
the post-synaptic response to a train of depolarizations can be to ei-
ther enhance or diminish subsequent signal transmission, the former
being long-term depression and the latter long-term potentiation
(LTP). Using ex vivo tissue sections, both presynaptic plasticity, as
measured by short-term PPF, and post-synaptic plasticity, as mea-
sured by LTP, were deﬁcient to different degrees in the knockout
strains. VDAC1−/− hippocampal slices exhibited a signiﬁcant deﬁcit
in LTP, while VDAC3−/− slices exhibited a signiﬁcant deﬁcit of PPF.
VDAC1−/−/VDAC3−/− deﬁcient slices were impaired in both pre-
and post-synaptic plasticity. Based upon VDAC1−/−/VDAC3−/− mice
showing synaptic plasticity phenotypes similar to those observed
in wildtype mice treated with the MPTP inhibitor CyclosporinA, it
was proposed that VDACs could play a role in calcium buffering or
calcium-induced calcium release in the presynaptic terminal as part
of theMPTP. Such a general regulation of calcium levels could possibly
affect kinases involved in synaptic plasticity such as Ca2+/calmodulin-
dependent protein kinase II, and a later study showed that calcium-
induced calcium release was indeed enhanced in VDAC1−/− isolated
brain mitochondria, providing a possible mechanism for the observed
alterations in plasticity [55]. However, while the MPTP may well be
perturbed by the absence of VDACs in the brain, additional studies
of MPTP function in other tissues and cell types lacking each VDAC
isoform failed to support a role for VDACs in the MPTP [56].6.3. A role in fertility
While mitochondrial function appears important for human fertil-
ity [57] and in particular male fertility, there are limited examples of
this in mousemodels. The previously mentioned infertility phenotype
of VDAC3−/− male mice is one such example [58]. While VDAC3−/−
males exhibit normal copulatory activity, they failed to impregnate
females in over 100matings, while VDAC3−/− females exhibit normal
fertility. The male infertility parallels that seen in male D. malanoga-
ster discussed earlier. To identify the cause, fertility assays examining
changes in sperm count, testes size, weight, histology and cellular ap-
optotic levels were performed, with VDAC3−/−males showing no dif-
ference from control in any of these characteristics. The VDAC3−/−
males did show reduced sperm motility (17% of the sperm were mo-
tile compared to 66% in control males) and most of the sperm were
not actively swimming after addition of various energy substrates.
There were also remarkable ultrastructural abnormalities in the
sperm, with most of the sperm axonemes in cross-section showing
the loss of one microtubule outer doublet from the normal 9+2
arrangement. The loss was highly speciﬁc when the axoneme were
bisected and observed in a particular orientation, with the same
single doublet (referenced as position #7) either missing or at inter-
mediate stages of loss, and the loss was only observed in sperm
from the cauda epididymis, not the testes, indicating that the loss is
a consequence of spermmaturation and not development. Ectopically
placed doublets, partial axoneme duplications, and loss of half the
doublets were also observed, but far less frequently. There was no
structural defect in the mitochondria observed in the midpiece of
sperm, but given the location of VDAC3 in mitochondria, these obser-
vations suggest that the microtubule architecture of the axoneme is
reliant on the presence or function of sperm MOM proteins.
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Studies using VDAC1−/− mice conﬁrmed the importance of this
protein as a carrier of metabolites across the MOM. It was found
that in detergent “skinned”muscle ﬁbers lacking VDAC1, where mito-
chondria are preserved in situ, there is a reduction in ADP-stimulated
oxygen consumption, suggesting reduced transport of ADP across the
outer and/or inner mitochondrial membranes in both cardiac and
skeletal muscle types [2]. Abnormal mitochondrial morphology in
the subsarcolemmal population of mitochondria of both the soleus
(oxidative) and the gastrocnemius (mixed oxidative/glycolytic) mus-
cle types was observed, with compact cristae and grossly enlarged
mitochondria. A follow-up report examining the role of VDAC3 in
MOM permeability and mitochondrial morphology using VDAC3−/−
mice was recently published [59], and demonstrated a similar effect
on ADP-stimulated respiration, but with the deﬁciency limited to car-
diac muscle ﬁbers, emphasizing that different VDAC isoforms are per-
forming different roles depending on their tissue location. Enlarged
mitochondria and irregular cristae structure, as was observed in the
VDAC1−/− mice, were present in the intermyoﬁbrillar and subsarco-
lemmal regions of the heart but not in gastrocnemius muscle in the
VDAC3−/− mice. Similar to VDAC1−/− mice, the absence of one
VDAC isoform did not alter the protein levels of the other isoforms
in the muscle. Defects in the electron transport chain (ETC) complex
activities in the muscles of both VDAC1−/− and VDAC3−/− mice
were also observed. There was a statistically signiﬁcant reduction in
Complex I+III, II+III and IV activities in VDAC1−/− muscles, and a
similar defect in Complex II activity in the gastrocnemius. There was
no defect in the Complex I and II activities in the heart of the
VDAC1−/− mice, while the VDAC3−/− heart showed a reduction in
Complex IV activity. Thus, absence of different VDAC isoforms leads
to diminished respiratory chain activities, however the biophysical
basis for these changes remains unknown; whether it reﬂects pertur-
bations in super-molecular respiratory complexes is an area currently
under investigation.
6.5. Regulating hexokinase interactions with mitochondria
Glycolysis is in part controlled through glucose phosphorylation
by the various isoforms of hexokinase. A large number of studies
have examined the binding of hexokinase to the MOM, where it pre-
sumably beneﬁts from the close proximity to the primary source of
ATP, and the proteins involved in the regulation of this binding have
all been under investigation for a few decades now [60]. The initial
identiﬁcation of VDAC1 as an interacting partner for binding to the
MOM was carried out by Nakashima et al. in 1986 [61], and has
since been supported by a number of other studies [4,62,63,64].
There is preferential glucose phosphorylation by ATP derived from
the mitochondrial matrix in comparison to ATP from the cytosol
([65]), and hexokinase binding to VDAC1 is reversible and is inhibited
by the product of the hexokinase reaction, glucose-6-phosphate.
This mitochondrial-bound hexokinase is an important aspect of the
Warburg effect; the increase in glycolysis in cancer cells even in the
presence of oxygen [66]. The VDAC1−/−, VDAC3−/− and VDAC1−/−
VDAC3−/− mice were therefore tested for levels of hexokinase in
the mitochondria of energy-demanding heart and muscle tissue
[67]. VDAC1−/− mice, but not VDAC3−/− mice, showed a signiﬁcant
reduction of mitochondria-associated hexokinase activity in heart
and soleus, but otherwise normal total tissue activity. To correlate
this result with the binding of HK2, the major hexokinase isoform
in heart and skeletal muscle, protein levels were measured from
skinned ﬁber mitochondrial preparations by Western blotting, and
there was a marked reduction of HK2 associated with VDAC1−/−
muscle mitochondria. To investigate the possibility of a physiological
regulatory role for HK-VDAC binding, glucose tolerance was exam-
ined, with VDAC1−/− and VDAC1−/−/VDAC3−/− mice showingsigniﬁcantly impaired glucose tolerance, whereas none was observed
in VDAC3−/− mice. The defective glucose clearance in VDAC1−/−
mice could be attributed to multiple factors, including a defect in
insulin secretion, excess gluconeogenesis, impaired glycogen synthe-
sis, or insulin resistance. Our lab has attempted to further characterize
the glucose intolerance using a hyperinsulinemic euglycemic clamp
experimental protocol. This approach has shown clear skeletal muscle
insulin resistance coupled with altered triglyceride synthesis and
transcriptional alterations in lipogenesis pathways in the VDAC1−/−
mice (unpublished results).
A signaling pathway connecting AKT signaling, HK-VDAC binding,
and apoptosis has been proposed, with AKT hypothesized to prevent
VDAC closure by phosphorylating and inhibiting mitochondria-
associated GSK3-β, which in turn inhibits HK-VDAC binding by phos-
phorylating VDAC and disassociating HK2 [64,68,69]. HK2 has been
proposed to inhibit apoptosis by inhibiting Bax-mediated cytochrome
c release and downstream apoptotic initiation [70,71,72], although a
speciﬁc mechanism for this has yet to be delineated. AKT signaling
is also directly implicated in glucose regulation by being downstream
of insulin receptor-mediated signaling and upstream of GLUT4 re-
cruitment to the cell surface and cellular glucose uptake [73,74,75].
Based on the observed skeletal muscle insulin resistance, we have
also investigated potential disruption of AKT signaling in VDAC1−/−
mice, and preliminary data indicate that there are changes in the
levels and phosphorylation status of the AKT signaling components
(unpublished results). By playing a potentially important role in cel-
lular AKT signaling and hexokinase activation, pathways that have
been implicated in glucose regulation and apoptosis, both of which
in turn have an important role in cancer biology, VDAC1, in addition
to the more-exhaustively investigated VDAC2, has been proposed
to be an attractive target for anti-cancer therapeutics (reviewed in
Ref. [76]).
6.6. Roles in apoptosis
There has been considerable interest in the role of VDACs in apo-
ptosis, beginning with a report implicating VDAC1 in the release of
cytochrome c [14]. VDAC1 has been the most studied isoform in cell
death processes (reviewed in Refs. [77] and [26]). However, the fact
that VDAC1 and VDAC3 deﬁcient animal models do not exhibit alter-
ations in apoptosis suggests that the role of these isoforms in cell
death as minor. Since the discovery that the pro-apoptotic multi-
domain protein BAK directly interacts with VDAC2 [78], a primary
focus has been on dissecting this relationship.
VDAC2, while genetically and structurally related to other two
VDAC isoforms, has distinct and unique properties. Studies of the in
vitro electrophysiological properties of mVDAC2 revealed that there
are two populations of channels that varied in conductance states
[45]. The presence of two populations of VDAC2 channels might
reﬂect cellular regulatory processes attributed speciﬁcally to VDAC2.
Mammalian VDAC2 also has additional 11–12 amino acids at the
amino terminus [10,30] that most likely inﬂuences its channel prop-
erties [79]. Studies of mutant mouse VDAC2 with substitutions of
ﬁve highly conserved amino acids further detailed its electrophysio-
logical properties. This VDAC2 mutant is constitutively “open” and
neutralizes the voltage sensor, exhibits normal ﬂux of anions, yet,
unlike wildtype VDAC2, fails to rescue the conditionally growth-
restrictive phenotype at 37 °C [80]. Hence, VDAC2 presents multiple
sub-states with different ionic selectivity and permeability relative
to the canonical VDAC1.
Unlike the viability of VDAC1, VDAC3, and double deﬁcient
VDAC1/VDAC3 mice, global elimination of VDAC2 gene results in
early stage mouse embryonic death [78]. The demonstration that
VDAC2 forms a speciﬁc protein complex with BAK and suppresses
BAK pro-apoptotic functions was a surprising discovery, yet is sup-
ported by further in vitro studies. Roy et al. conﬁrmed that VDAC2
Table 2
Summary of mouse model systems available to investigate VDAC deﬁciency.
nVDAC1 nVDAC2 nVDAC3 Ref
▪ Mouse models available Whole body knockout Heart and Thymus conditional
knockouts
Whole body knockout [47,83],
Unpublished data
▪ Survival and growth Pups born with less than Mendelian
frequency, Mild growth retardation
No survivors with whole-body
knockout Conditional knockouts
show shortened lifespan
Normal growth and survival [47,78],
Unpublished data
▪ Mouse model deﬁciency
phenotypes
Glucose intolerance, insulin resistance.
Defects in spatial learning, cued fear
conditioning, long-term potentiation
Defects in apoptotic pathway
affecting survival
Infertility, reduced sperm motility.
Defects in contextual fear conditioning,
spatial learning, paired pulse facilitation
[47,58,67,83]
Unpublished data
▪ Knockout cell lines ES cells, MEFs, Epithelial cells ES cells, Cardiomyocytes,
Thymocytes
ES cells, MEFs [46,47,58,67,78,83],
Unpublished data
▪ Cellular phenotypes Reduced ADP diffusion, defects in ETC
complexes, larger mitochondria and
more compact cristae in certain muscle
types. Reduced Hexokinase binding to
MOM and possible altered Akt signaling
Altered apoptotic response to ER
stress, abnormal Bak activity
Reduced ADP diffusion, defects in ETC
complexes, larger mitochondria and
more compact cristae in cardiac muscle
[46,47,58,67,78,83]
Unpublished data
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MOM permeabilization and cell death [81]. It has since been shown
that inactive BAK exists in large complexes with VDAC2; these com-
plexes constitutively localize to the MOM, and the native transmem-
brane anchor of BAK is required for its association with VDAC2 [82].
The necessity of VDAC2 for normal development has slowed pro-
gress in uncovering the in vivo role of VDAC2. Using conditional dele-
tion of VDAC2 in lymphocytes, Cheng and colleagues showed that
there was rapid cell death that could be rescued by the parallel dele-
tion of BAK [83]. Using a similar conditional mutation strategy, we
have also analyzed the consequences of the loss of VDAC2 in vivo.
Deletion of VDAC2 from the mouse heart leads to the postnatal
onset of progressive ﬁbrosis and cardiomyopathy, resulting in early
mortality. Similarly, concomitant deletion of BAK reverses the cardiac
dysfunction. In cells lacking VDAC2, BAK is displaced from mitochon-
dria and re-locates to the endoplasmic reticulum (ER). This alters the
expression of a number of ER stress-related genes, and inhibits phar-
macologically provoked ER stress-related apoptosis, that again can be
rescued by elimination of BAK (unpublished results). We hypothesize
that the accumulation of BAK in the ER leads to a novel gain of func-
tion and aberrant stress responses due to perturbations in ER calcium
homeostasis.
VDAC2 is expressed in all mammalian tissues at varied levels [10].
It will be interesting to study the consequences of VDAC2 elimination
in tissues such as the brain and testes where it is expressed the most,
and conversely over-express VDAC2 in tissues such as the liver and
kidney where the protein is normally found at low levels.
6.7. Other phenotypes
In addition to serving as a model system for studying direct observ-
able phenotypes resulting from the absence of VDACs, the effects of
VDAC loss of function mutations in conjunction with other mutant
loci has begun to be addressed. An example of such an investigation
was the study by Isrealson et al., where the interaction between
Superoxide Dismutase 1 (SOD1) and the cytosol-facing domain of
VDAC1 was elucidated using VDAC1+/− mice [84]. Mutations in SOD1
has been implicated as a cause of at least 20% of familial Amyotrophic
Lateral Sclerosis, a progressive neurodegenerative disorder caused by
selective loss of both the afferent cortical neurons in the brain and the
ventral horn neurons in the spinal cord [85]. Since there is increased ac-
cumulation of mutant SOD1 on the MOM in animal models and patient
samples, the authors investigated a possible role for VDAC1 in ALS, by
crossing VDAC1+/− mice with mice harboring the SOD1G37R mutation
[86]. The SOD1G37R mice exhibit axial tremors, asymmetric weakness
and progressive paralysis of limbs, all of which are associated with ex-
tensive vacuolization and mitochondrial degradation in the motorneurons. The VDAC1+/−/SOD1G37R mice showed accelerated onset,
progression and attainment of end-stage disease when compared to
the SOD1G37R mice. This phenotype was proposed to be a result of the
loss of VDAC leading to reduced ATP/ADP/metabolite permeability, a
drop in inner membrane Δψm, accelerated mitochondrial dysfunction,
increased ROS, and increased misfolding of SOD1.
The VDAC deﬁcient mice have also been used to isolate primary
cell lines that can be used for in vitro experimentation. The study by
Okada et al., for example, isolated primary ﬁbroblasts and respiratory
epithelial cells from VDAC1−/− mice to characterize the role of
VDAC1 in ATP release across the plasma membrane and the conse-
quent release-dependant volume changes in response to hypotonic
challenge [87]. Other studies using primary VDAC1−/−, VDAC2−/−,
VDAC3−/− cell lines for in vitro experiments addressing mechanisms
of apoptosis are underway.
In summary, animal models provide a level of biological complex-
ity not present in more simple organisms and have been instrumental
in uncovering interesting biological functions for the individual iso-
forms (Table 2). There are numerous areas of physiology, biochemis-
try, and genetics that remain to be explored. Based upon both their
function and location, VDAC isoforms may be novel targets in the
development of new therapeutics.
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